There has been significant media interest in an announcement by scientists at Oxford University and King's College in the United Kingdom about the development of a blood test for Alzheimer's disease, Alzheimers NZ has issued the following statement:
“We are pleased to see a continued focus on growing knowledge about dementia, particularly in the area of diagnosis and detection,” says Alzheimers NZ Executive Director Catherine Hall.
“Early diagnosis and detection of all forms of dementia including Alzheimer’s disease is critically important in the treatment and management of the condition, and is something that we advocate strongly for.
“Receiving a diagnosis allows people affected by dementia to access services and support from local Alzheimers organisations and gives them the opportunity to plan for their future. Diagnostic tools such as this would be very helpful in detecting dementia in its early stages, and may add to the ability to do further research into prevention of dementia.
“However it is early days for this study and further trials are required with a diverse range of people before its effectiveness can be determined.
"While it is encouraging that dementia research is continuing, we are yet to see many significant research developments progress to large scale clinical trials, and subsequently to a treatment or cure for this complex condition."
Site by Kudos Web
Ctrl + 1 Home
Ctrl + 2 About Dementia
Ctrl + 3 Get Support
Ctrl + 4 Get Involved
Ctrl + 5 News & Info
Ctrl + 6 Who we are
Ctrl + 7 Contact us
Ctrl + 8 Donate
Ctrl + 9 Search